How long Medicare pays for anti-rejection drugs depends on why you qualify for Medicare and what type of organ you received. If you have Medicare because of age (65+) or a disability, coverage for immunosuppressive drugs continues for as long as you keep Part B. The time limit only applies to people who qualify for Medicare solely because of end-stage renal disease (ESRD), and even that limit now comes with an important safety net.
The 36-Month Rule for Kidney Transplant Recipients
If you became eligible for Medicare only because of permanent kidney failure, your entire Medicare coverage, including immunosuppressive drugs, ends 36 months after the month of a successful kidney transplant. This applies specifically to people who don’t otherwise qualify through age or another disability. Once those 36 months are up, Medicare stops paying for everything: doctor visits, lab work, hospital stays, and medications.
This cutoff created a serious problem. Anti-rejection drugs are not optional after a transplant. Missing them can lead to organ rejection, which means going back on dialysis or needing another transplant. For years, many kidney recipients lost their transplants simply because they could no longer afford the medications once Medicare ended.
The Part B-ID Benefit: Lifetime Drug Coverage
Starting January 1, 2023, Medicare created a new benefit called Part B-ID (Immunosuppressive Drug) that provides lifetime coverage of anti-rejection medications for kidney transplant recipients whose 36-month coverage has ended. This benefit covers immunosuppressive drugs only. It does not restore your other Medicare benefits like doctor visits, hospital care, or lab work.
To qualify for Part B-ID, you must meet all three conditions:
- You received your kidney transplant at a Medicare-approved facility while covered by Part A.
- Your regular Medicare coverage based on ESRD has ended (the 36-month post-transplant window has closed).
- You don’t have other health coverage that already pays for immunosuppressive drugs.
The list of disqualifying coverage is broad. You cannot enroll in Part B-ID if you have an employer or individual health plan, a Marketplace plan, TRICARE, Medicaid or CHIP that covers immunosuppressive drugs, or VA coverage. The benefit is designed as a last resort for people who would otherwise have no way to pay for these medications.
What Part B-ID Costs in 2025
Part B-ID is not free. In 2025, the standard monthly premium is $110.40, with a $257 annual deductible. After you meet that deductible, you pay 20% of the Medicare-approved amount for your immunosuppressive drugs. Higher-income beneficiaries pay more: premiums can reach $552.10 per month for individuals earning $500,000 or more. For most people, though, the $110.40 premium plus the 20% coinsurance is significantly cheaper than paying full price for anti-rejection medications out of pocket, which can run thousands of dollars a month.
Heart, Liver, and Lung Transplants
The 36-month cutoff is unique to kidney transplant recipients who qualify for Medicare through ESRD. If you had a heart, liver, lung, or other organ transplant and Medicare helped pay for it, your immunosuppressive drug coverage under Part B continues for as long as you maintain Part B enrollment. There is no expiration date built into coverage for non-kidney transplants.
The key requirement is that Medicare must have helped pay for the transplant itself. You need to have had Part A at the time of the transplant surgery and Part B at the time you fill your immunosuppressive prescriptions. If your transplant was covered entirely by private insurance and Medicare was not involved, Part B will not cover your anti-rejection drugs. In that case, you would need to get them through a Part D prescription drug plan or other coverage.
Part B vs. Part D for Anti-Rejection Drugs
Medicare Part B covers immunosuppressive drugs when Medicare paid for your transplant. Part D, the prescription drug benefit, covers medications that Part B does not. If your transplant was not a Medicare-covered procedure, or if you need related medications that fall outside the immunosuppressive drug category, Part D may be your coverage path. Checking your Part D plan’s formulary is important because not every plan covers the same drugs at the same cost tier.
For people with Medicare-covered transplants, Part B is typically the better deal for anti-rejection drugs specifically, since it has no coverage gap and the 20% coinsurance is straightforward. But you may still want Part D for other prescriptions unrelated to your transplant.
Avoiding a Coverage Gap
If you qualify for Medicare only through ESRD, planning ahead is critical. Your 36-month countdown begins the month of your successful kidney transplant, not the month you leave the hospital or stop all follow-up care. As that deadline approaches, you should evaluate whether you qualify for Part B-ID or whether another insurance option, such as an employer plan, Marketplace coverage, or Medicaid, can pick up your immunosuppressive drugs without interruption. A gap in anti-rejection medication, even a short one, puts your transplanted kidney at risk.